← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:1088 | 1088 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1088 | 1088 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2300 | 72934-2300-2 | Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1088 | 1088 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1088 | 1088 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1088 | 1088 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6007 | 72196-6007-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1088 | 1088 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1088 | 1088 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Potassium Chloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1089 | 1089 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1028 | 73013-1028-1 | Fentanyl Citrate- Bupivacaine HCl | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1089 | 1089 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1089 | 1089 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1089 | 1089 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1089 | 1089 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-50 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1089 | 1089 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 54288-804 | 54288-804-01 | Methylene Blue | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1089 | 1089 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5156 | 26436-5156-1 | Methylcobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1089 | 1089 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1089 | 1089 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5100 | 71266-5100-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1089 | 1089 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8095 | 71285-8095-1 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1089 | 1089 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2304 | 72934-2304-2 | Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1089 | 1089 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1089 | 1089 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-040 | 71506-040-10 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1089 | 1089 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-045 | 70092-045-05 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1089 | 1089 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7084 | 71139-7084-2 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1089 | 1089 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-127 | 73177-127-05 | Potassium Chloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1090 | 1090 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8475 | 71266-8475-3 | Mitomycin | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1090 | 1090 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1090 | 1090 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1337 | 61141-1337-1 | Midazolam | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1090 | 1090 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9130 | 51754-9130-1 | Midazolam Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1090 | 1090 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-022 | 71449-022-32 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1090 | 1090 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1090 | 1090 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5354 | 26436-5354-1 | Methylene Blue | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1090 | 1090 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1090 | 1090 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1090 | 1090 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8096 | 71285-8096-1 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1090 | 1090 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1413 | 72934-1413-2 | Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1090 | 1090 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1090 | 1090 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-029 | 71506-029-58 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1090 | 1090 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1090 | 1090 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1090 | 1090 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-6429 | 83863-6429-1 | Potassium Chloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1091 | 1091 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-281 | 70092-281-08 | Hep 30,000 U add to 1000 ml NS bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1091 | 1091 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1091 | 1091 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1091 | 1091 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9131 | 51754-9131-5 | Midazolam Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1091 | 1091 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-021 | 71449-021-11 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1091 | 1091 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1091 | 1091 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 54288-804 | 54288-804-01 | Methylene Blue | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1091 | 1091 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1091 | 1091 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-085 | 70004-085-44 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1091 | 1091 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7036 | 71285-7036-1 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1091 | 1091 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2306 | 72934-2306-2 | Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1091 | 1091 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1091 | 1091 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-045 | 70092-045-05 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1091 | 1091 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6058 | 71285-6058-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1091 | 1091 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-115 | 73177-115-25 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1091 | 1091 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Potassium Chloride; Magnesium Sulfate Heptahydrate; Lidocaine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1092 | 1092 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0651 | 83863-0651-1 | Rocuronium Bromide 50 mg in 5 mL (10 mg/mL) | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1092 | 1092 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1092 | 1092 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1092 | 1092 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1092 | 1092 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-6 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1092 | 1092 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3119 | 62295-3119-1 | Methylprednisolone Acetate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1092 | 1092 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-5 | Methylprednisolone Acetate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1092 | 1092 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1092 | 1092 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1092 | 1092 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8097 | 71285-8097-1 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1092 | 1092 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2309 | 72934-2309-2 | Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1092 | 1092 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1092 | 1092 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1092 | 1092 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7025 | 71285-7025-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1092 | 1092 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9032 | 71266-9032-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1092 | 1092 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-745 | 69194-745-01 | Povidone-Iodine | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1093 | 1093 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1571 | 72934-1571-2 | Adalina | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1093 | 1093 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1093 | 1093 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1093 | 1093 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1093 | 1093 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-4 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1093 | 1093 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1065 | 71266-1065-1 | Methylprednisolone Acetate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1093 | 1093 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-3 | Methylprednisolone Acetate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1093 | 1093 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1093 | 1093 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1093 | 1093 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6056 | 72196-6056-1 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1093 | 1093 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2307 | 72934-2307-2 | Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1093 | 1093 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1093 | 1093 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-033 | 71506-033-58 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1093 | 1093 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7039 | 72196-7039-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1093 | 1093 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-127 | 73702-127-10 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1093 | 1093 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-8300 | 70168-8300-1 | Prasterone; Testosterone Cypionate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1094 | 1094 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2112 | 72627-2112-3 | Testosterone Cypionate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1094 | 1094 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1094 | 1094 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1094 | 1094 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1094 | 1094 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-5 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1094 | 1094 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3121 | 62295-3121-7 | Methylprednisolone Acetate; Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1094 | 1094 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1094 | 1094 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1094 | 1094 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5030 | 70214-5030-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1094 | 1094 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5015 | 71266-5015-1 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1094 | 1094 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2308 | 72934-2308-2 | Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1094 | 1094 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1094 | 1094 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-031 | 71506-031-51 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1094 | 1094 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6092 | 71285-6092-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1094 | 1094 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9030 | 71266-9030-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1094 | 1094 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0630 | 70168-0630-1 | Prasterone; Testosterone Cypionate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1095 | 1095 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 67157-006 | 67157-006-30 | Methylcobalamin | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1095 | 1095 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1095 | 1095 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1095 | 1095 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1095 | 1095 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-1 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1095 | 1095 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1095 | 1095 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1095 | 1095 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1095 | 1095 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1095 | 1095 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5015 | 71266-5015-2 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1095 | 1095 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-510 | 71170-510-25 | Norepinephrine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1095 | 1095 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1095 | 1095 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-055 | 71506-055-10 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1095 | 1095 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7011 | 71285-7011-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1095 | 1095 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9011 | 71266-9011-9 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1095 | 1095 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1096 | 1096 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1073 | 73013-1073-1 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1096 | 1096 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1096 | 1096 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4031 | 71286-4031-1 | Midazolam Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1096 | 1096 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1096 | 1096 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-3 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1096 | 1096 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1096 | 1096 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1096 | 1096 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2503 | 72627-2503-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1096 | 1096 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-121 | 73702-121-06 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1096 | 1096 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5025 | 71266-5025-1 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1096 | 1096 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-550 | 71170-550-25 | Norepinephrine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1096 | 1096 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1096 | 1096 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-002 | 71506-002-58 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1096 | 1096 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1096 | 1096 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-125 | 73702-125-10 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1096 | 1096 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1097 | 1097 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2590 | 72934-2590-2 | Admirazol | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1097 | 1097 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1097 | 1097 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-1 | Midazolam Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1097 | 1097 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4031 | 71286-4031-2 | Midazolam Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1097 | 1097 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1097 | 1097 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1097 | 1097 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1097 | 1097 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2504 | 72627-2504-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1097 | 1097 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-068 | 70092-068-07 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1097 | 1097 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5025 | 71266-5025-2 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1097 | 1097 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-500 | 71170-500-25 | Norepinephrine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1097 | 1097 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1097 | 1097 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1097 | 1097 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1418 | 61141-1418-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1097 | 1097 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-125 | 73702-125-15 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1097 | 1097 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1098 | 1098 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-323 | 69374-323-25 | Fentanyl Citrate in 0.9% Sodium Chloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1098 | 1098 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Tretinoin; Minoxidil; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1098 | 1098 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4031 | 71286-4031-2 | Midazolam Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1098 | 1098 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4031 | 71286-4031-1 | Midazolam Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1098 | 1098 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1098 | 1098 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1098 | 1098 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1098 | 1098 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1098 | 1098 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-120 | 73702-120-05 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1098 | 1098 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8096 | 72196-8096-1 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1098 | 1098 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-520 | 71170-520-25 | Norepinephrine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1098 | 1098 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1098 | 1098 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9010 | 71266-9010-9 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1098 | 1098 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-485 | 70092-485-46 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1098 | 1098 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8211 | 71266-8211-1 | Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride; Tropicamide | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1098 | 1098 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1099 | 1099 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73217-002 | 73217-002-10 | Tacrolimus 0.03% Ophth | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1099 | 1099 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Tretinoin; Minoxidil; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1099 | 1099 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-2 | Midazolam Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1099 | 1099 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-016 | 71449-016-32 | Midazolam Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1099 | 1099 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2041 | 71286-2041-2 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1099 | 1099 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1099 | 1099 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1099 | 1099 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1099 | 1099 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-015 | 73198-015-10 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1099 | 1099 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8097 | 72196-8097-1 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1099 | 1099 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5040 | 70214-5040-1 | Norepinephrine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1099 | 1099 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1099 | 1099 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5230 | 71266-5230-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1099 | 1099 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-046 | 70092-046-46 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1099 | 1099 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8211 | 71266-8211-5 | Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride; Tropicamide | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1099 | 1099 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9055 | 83826-9055-5 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1100 | 1100 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9006 | 83826-9006-5 | Timolol , Brimonidine, Dorzolamide | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1100 | 1100 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-3 | Midazolam Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6795 | 60652-6795-2 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-314 | 69374-314-05 | Midazolam | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1100 | 1100 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-018 | 79926-018-06 | Pentosan Polysulfate Sodium | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-015 | 73198-015-03 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6057 | 72196-6057-1 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5025 | 71266-5025-2 | Norepinephrine Bitartrate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1100 | 1100 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0104 | 60652-0104-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-486 | 70092-486-46 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-608 | 69194-608-01 | Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride; Tropicamide | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1100 | 1100 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-002 | 81375-002-05 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1101 | 1101 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-22 | Bevacizumab | 2024-2 | valid | 0 | 2026-09-18 |